GLP-1 Receptor Agonists Are Reshaping the Future of Obstructive Sleep Apnea Care
https://researchintelo.com/rep....ort/glp-1-receptor-a
The GLP-1 receptor agonist for obstructive sleep apnea market was valued at $0.4B in 2025 and is projected to reach $4.8B by 2034, growing at 47.2% CAGR. Obstructive sleep apnea (OSA) is one of the most common sleep-related breathing disorders worldwide, affecting millions of adults and an increasing number of younger individuals.
پسند
تبصرہ
بانٹیں
